Skip to content

Cytokine-Associated Depression and Social Pain

An fMRI Study of Cytokine-Associated Depression and Social Pain

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00949845
Enrollment
Unknown
Registered
2009-07-30
Start date
2007-01-31
Completion date
Unknown
Last updated
2009-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Keywords

Effect of Inflammatory challenge on depressed mood, Effect of inflammatory challenge on social pain

Brief summary

Recent research has demonstrated a relationship between depression and immune system activity, specifically proinflammatory cytokine activity. Although experimentally-induced immune activation leads to increases in depressed mood, the neural correlates associated with these changes have remained largely unexplored. Based on relationships between cytokine activity, depression, and heightened physical and social pain sensitivity, I propose to investigate the effect of proinflammatory cytokine activation on the neural correlates of socially painful experience that may contribute to depression. Our previous work has shown that the dorsal anterior cingulate cortex (dACC), typically associated with physical pain distress, also plays a role in the distressing feelings associated with social rejection or social loss. Moreover, recent pilot data has revealed that individuals with elevated levels of baseline proinflammatory cytokines report feeling more distressed and show more dACC activity during social rejection. To investigate the causal role that cytokines may play in the heightened social pain sensitivity that can contribute to depression, participants will be randomly assigned to receive either endotoxin (which increases proinflammatory cytokine activity) or placebo. Subsequently, participants will complete a neuroimaging study in which they will be rejected during an online ball-tossing game. We hypothesize that individuals exposed to endotoxin will report more social distress and depression following rejection and will show more dACC reactivity during rejection. The proposed study is the first to investigate the effect of systemic inflammation on neural reactivity related to social and affective processes that may increase the risk of depression.

Interventions

DRUGEndotoxin

Sponsors

University of California, Los Angeles
Lead SponsorOTHER

Study design

Primary purpose
BASIC_SCIENCE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* right-handed

Exclusion criteria

* 1\) BMI greater than 30, * 2\) presence of physical health problems or medication use, * 3\) evidence of an Axis I psychiatric disorder based on the SCID assessment, * 4\) evidence of recreational drug use from a positive urine test, * 5\) positive pregnancy test, if female, * 6\) abnormalities on screening laboratory tests (blood cell count, liver function), * 7\) claustrophobia, * 8\) metal in body, * 9\) history of allergies, autoimmune, liver, or other severe chronic diseases, * 10\) current use of prescription medications, * 11\) nightshift work or time zone shifts (\> 3hrs) within the previous 6 weeks.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026